Business Context and Reporting Period
Company: Achieve Life Sciences, Inc. (ACHV)
Filing Type: Form 8-K (Current Report)
Report Date: August 13, 2024
Event: Announcement of financial results for the second quarter ended June 30, 2024.
Key Financial Metrics
The provided Form 8-K text serves as a notification of the results announcement and does not contain specific financial data points. The filing states that the detailed results are contained in a press release furnished as Exhibit 99.1. Consequently, the following metrics are not available in the source text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
The Form 8-K text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document explicitly notes that the information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 13, 2024) for actual Q2 2024 financial figures.
- Verify the company's cash runway and liquidity position in the full press release, as this is critical for a life sciences entity.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the press release.
- Confirm if the company provided updated full-year 2024 guidance in the press release.